Citigroup’s CureVac CVAC Stock Holding History

Citigroup’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,500	Closed	-$257K	–	6352
2021 Q4	$257K	Hold	7,500	–	–	﹤0.01%	4207
2021 Q3	$410K	Buy	+7,500	New	+$452K	﹤0.01%	3748

Other funds holding CVAC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Citigroup's CVAC Position: Q4 2025 in Review

Citigroup sold out of CureVac (CVAC) in Q4 2025, closing a stake of 216,875 shares — an estimated $1.17M sold.

Citigroup first reported a position in CVAC in Q3 2020 and held it in 21 quarters. The position peaked at $13.1M in Q2 2021. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

Citigroup reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
Citigroup sold 216,875 CureVac shares in Q4 2025, an estimated $1.17M.
Citigroup first reported a position in CureVac in Q3 2020 and held it in 21 quarters.
Citigroup's CureVac position peaked at $13.1M in Q2 2021.
57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.